Topic

Michigan

A collection of 504 issues

The Requirements Checklist to Get Ultomiris (ravulizumab) Covered by Aetna (CVS Health) in Michigan: Forms, Appeals, and Approval Timeline

Answer Box: Getting Ultomiris (ravulizumab) Covered by Aetna (CVS Health) in Michigan Aetna requires prior authorization for Ultomiris (ravulizumab) across all FDA-approved indications (PNH, aHUS, anti-AChR+ myasthenia gravis, AQP4+ NMOSD). Your fastest path to approval: 1) Verify active coverage and specialty pharmacy benefits, 2) Complete Aetna's precertification form
6 min read

Work With Your Doctor to Get Emflaza (deflazacort) Approved by UnitedHealthcare in Michigan: Complete Provider Collaboration Guide

Quick Answer: Getting Emflaza Approved in Michigan UnitedHealthcare requires prior authorization for Emflaza (deflazacort) with step therapy requirements for DMD patients. Your best path: work closely with your neurologist to document DMD diagnosis, failed trials of prednisone/prednisolone, and functional assessments. Submit through the UnitedHealthcare Provider Portal for fastest processing.
6 min read

Get Elevidys Covered by UnitedHealthcare in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Elevidys Covered by UnitedHealthcare in Michigan UnitedHealthcare requires prior authorization for Elevidys (delandistrogene moxeparvovec-rokl) gene therapy, with mandatory step therapy through corticosteroids first. To get approved: (1) Document failed prednisone/prednisolone trials with doses and duration, (2) Submit genetic DMD confirmation and anti-AAVrh74 antibody testing showing titer
5 min read

How to Get Alecensa (Alectinib) Covered by UnitedHealthcare in Michigan: Complete Prior Authorization Guide

Answer Box: Getting Alecensa Covered by UnitedHealthcare in Michigan UnitedHealthcare requires prior authorization for Alecensa (alectinib) in Michigan for ALK-positive NSCLC, with no step therapy requirements. Submit PA through the UnitedHealthcare Provider Portal with ALK test results, oncologist prescription, and diagnosis documentation. If denied, file internal appeal within 30 days,
6 min read